Orbimed Advisors - OPHTHOTECH CORP ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of OPHTHOTECH CORP
ValueSharesWeighting
Q3 2016$53,797,000
-50.9%
1,166,200
-45.7%
0.61%
-46.4%
Q2 2016$109,618,000
+23.8%
2,148,100
+2.6%
1.14%
+22.7%
Q1 2016$88,535,000
-44.0%
2,094,500
+4.1%
0.93%
-34.8%
Q4 2015$157,963,000
+102.7%
2,011,500
+4.6%
1.43%
+81.7%
Q3 2015$77,940,000
-10.6%
1,923,500
+14.9%
0.79%
+23.0%
Q2 2015$87,180,000
+12.3%
1,674,600
+0.4%
0.64%
-3.5%
Q1 2015$77,640,000
+100.8%
1,668,600
+93.6%
0.66%
+79.2%
Q4 2014$38,669,000
+193.2%
861,800
+154.4%
0.37%
+168.1%
Q3 2014$13,189,000
+1081.8%
338,800
+882.0%
0.14%
+762.5%
Q4 2013$1,116,00034,5000.02%
Other shareholders
OPHTHOTECH CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,487,209$9,834,0005.80%
Tamarack Advisers, LP 775,000$2,186,0001.34%
ARMISTICE CAPITAL, LLC 3,364,000$9,486,0001.12%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 16,110$45,0000.09%
DAFNA Capital Management LLC 50,000$141,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 448,841$1,265,0000.09%
Nine Chapters Capital Management LLC 13,500$38,0000.08%
Spark Investment Management LLC 214,800$605,0000.03%
Quinn Opportunity Partners LLC 65,000$183,0000.03%
Highlander Capital Management, LLC 6,000$17,0000.01%
View complete list of OPHTHOTECH CORP shareholders